ArticleCancer management and research2026

Early On-Treatment Expansion of Peripheral γδT Cells as a Noninvasive Biomarker of Response to Programmed Death-1 Inhibitor Therapy in Advanced Non-Small Cell Lung Cancer.

ZiYi Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.